MeSH tree: C12.100.250.056.630
Polycystic Ovary Syndrome, which has just been renamed Polyendocrine Ovarian Syndrome (PMOS), is the most common hormonal and metabolic disorder affecting women of reproductive age, impacting up to 13% of this population ...
May 18, 2026
0
7
When Mayo Clinic researchers sequenced the genomes of 484 seemingly healthy adults, they found that about 13% carried a serious, previously unrecognized genetic risk—conditions those patients did not know about and that standard ...
May 14, 2026
0
4
A global effort led by Monash University has changed the name of a significant women's health condition that was misunderstood to be "all about ovarian cysts." Polyendocrine metabolic ovarian syndrome (PMOS) is the new name ...
May 12, 2026
0
17
Heart disease risk has been found to increase in women with polycystic ovary syndrome (PCOS), even in those with normal weight, according to research presented at the 28th European Congress of Endocrinology in Prague. This ...
May 11, 2026
0
12
A new scoping review from the University of Toronto reveals that caregivers of loved ones with ovarian cancer face significant emotional strain, heavy caregiving responsibilities, and limited support throughout the disease ...
Apr 30, 2026
0
3
Each month during a woman's menstrual cycle, an ovary prepares 10–20 antral follicles, fluid-filled sacs that hold immature eggs, for maturation. In most cycles, only one follicle is selected to undergo maturation, eventually ...
Apr 23, 2026
0
7
Metformin has a strong claim to being one of the most influential medicines of the past century. For decades, it has underpinned the treatment of type 2 diabetes, helped millions of people control their blood sugar, and inspired ...
Apr 20, 2026
0
6
Polycystic ovary syndrome, or PCOS, affects as many as 18% of all childbearing-age women. The condition occurs when a woman's body produces too much of a group of hormones called androgens, chiefly testosterone. Menstrual ...
Apr 4, 2026
0
25
Hiroshima University researchers have developed a practical framework to identify candidate pathogenic variants hidden among the large number of variants of uncertain significance (VUS) detected in comprehensive genomic profiling ...
Mar 31, 2026
0
5
Stress is a constant companion in the oncologist's office. It appears at the time of diagnosis, increases with each stage of treatment, and often does not resolve even after therapy formally ends. It accompanies therapeutic ...
Mar 24, 2026
0
13
